Document is current
Any future updates will be listed below
-
Authors
Germain, Anne https://orcid.org/0000-0001-6672-4800
Markwald, Rachel R.
King, Erika
Bramoweth, Adam D.
Wolfson, Megan
Seda, Gilbert
Han, Tony
Miggantz, Erin
O’Reilly, Brian
Hungerford, Lars
Sitzer, Traci
Mysliwiec, Vincent
Hout, Joseph J.
Wallace, Meredith L.
-
Funding
Funding for this research was provided by:
Medical Technology Enterprise Consortium (2019-406)
US Air Force Medical Readiness Agency (FA8052-19C-A010.NOCTEM.001)
- License Information
-
More Information
Article History
Received: 18 June 2020
Accepted: 14 December 2020
First Online: 11 January 2021
Ethics approval and consent to participate
: This study received ethics review and approval from Solutions, IRB (Protocol #2019/12/10) on January 29, 2020; from the Naval Health Research Center (NHRC) on April 28, 2020 (Protocol #: NHRC.2019.0018); and from the US Army Medical Research and Development Command (USAMRDC), Office of Research Protections (ORP), Human Research Protection Office (HRPO) (HRPO Log Numbers E01442.1a [NOCTEM, LLC], E01442.1b [NHRC], E01442.1e [Naval Medical Center, San Diego], and E01442.1f [Naval Hospital Camp Pendleton]) on September 11, 2020. Consent will be obtained from all providers and end users interested in participating in the trial.
: Not applicable.
: AG is co-founder and CEO of NOCTEM, LLC. ADB is supported by the Department of Veterans Affairs, Health Services Research and Development Service (IK2 HX-001548, I01 HX003096). VM is consultant for CPAP Medical, Ebb Therapeutics, and NightWare, Inc. ADB, MLW, and VM are paid consultants of NOCTEM, LLC. MW is employed by NOCTEM, LLC.
